Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Ian F. Dunn et al.|Nature|2009Cited by 4.2k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsJ.M. Ostrem, Kevan M. Shokat, Ulf Peters et al.|Nature|2013Cited by 2.5k
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Matthew R. Guthrie et al.|Cancer Cell|2017Cited by 607
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer ModelingJuliann Chmielecki, William Pao, Jasmine Foo et al.|Science Translational Medicine|2011Cited by 530
A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1Nicholas T. Hertz, Kevan M. Shokat, Amandine Berthet et al.|Cell|2013Cited by 274